Last reviewed · How we verify
NCT03105024
Self-efficacy Enhancement and Exposure Therapy
NA trial testing Self-efficacy enhancement in Specific Phobia in 71 participants. Completed in 29 November 2017.
29 November 2017
Quick facts
| Lead sponsor | Ruhr University of Bochum |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 71 |
| Start date | 22 March 2017 |
| Primary completion | 29 November 2017 |
| Estimated completion | 29 November 2017 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- Self-efficacy enhancement
- Control intervention — full drug profile →
Conditions studied
- Specific Phobia — all drugs for Specific Phobia →
Sponsor
Ruhr University of Bochum
Who can join
Adults 18 to 38, any sex, with Specific Phobia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Self-efficacy refers to the perceived belief to cope effectively, by personal efforts, with challenging situations and problems (Bandura, 1977). Basic research has shown that increases in perceived self-efficacy can enhance the extinction of fear (Zlomuzica et al., 2015). This study is aimed at translating these findings into a useful clinical application to augment exposure-based treatment outcome.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03105024
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Specific Phobia
Currently open trials in the same condition.
- NCT07228143 — Stepped Care Treatment for Anxiety Resilience · NA · recruiting
- NCT06661460 — Internet-Delivered Cognitive Behavioral Intervention for Youths With Anxiety Disorders · NA · recruiting
- NCT06942429 — Stepped Versus Stratified Care for Anxiety Disorders in Youth · NA · recruiting
- NCT06788119 — Analyzing the Benefits of Using SYMPTOMS-JIT for in Vivo Exposure in Anxiety Disorders · NA · recruiting
- NCT04563390 — Effectiveness of a Projection-based Augmented Reality Exposure System in Treating Cockroach Phobia. · NA · recruiting
Other Ruhr University of Bochum trials
Trials by the same sponsor.
- NCT07432945 — In Vivo Exposure vs. Videochat-Based Vicarious Exposure · NA · recruiting
- NCT06255821 — The Effect of Time on Generalization of Exposure-based Benefit · NA · completed
- NCT05824884 — Self-efficacy Enhancement in a Virtual Reality Training for Fear of Heights · NA · recruiting
- NCT05798078 — The Relationship Between Social Anxiety and Anxious Thinking Styles · NA · completed
- NCT05780203 — CBM in the Context of Exposure for Acrophobia · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03105024 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ruhr University of Bochum
- Last refreshed: 11 April 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03105024.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing